Palogic Value Management, L.P.

Position in ACTU — Actuate Therapeutics, Inc.

CIK 1532943 DALLAS, TX

Position in ACTU

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$153,000

-$121,000 QoQ

Shares Held

100,000

0.0% QoQ

Ownership

0.416%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

of 64 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Palogic Value Management, L.P. holds $967,590 across 4 Biotechnology names. ACTU ranks #4 (15.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RGNX	REGENXBIO Inc.	30,040	$359,879
2	IRD	Opus Genetics, Inc.	65,088	$267,511
3	RNTX	Rein Therapeutics, Inc.	180,000	$187,200
4	ACTU	Actuate Therapeutics, Inc. This page	100,000	$153,000

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$153,000	100,000	0.0%	Shares	Sole	2026-08-14
2026-03-31	$274,000	100,000	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.